Alphamab Oncology Doses First Patient in Phase III JSKN003 Study for HER2-Positive Advanced Colorectal Cancer

Love, Written in Courage: Valentine’s Day Letters from the OncoDaily Followers 2026

How Bacteria May Promote Breast Cancer: The Emerging Role of SMOX

Nutrition Across the Cancer Continuum: Prevention, Treatment, Recovery

Pashtoon Kasi: NIPT Technology Beyond Pregnancy - ctDNA Detection in Cancer

Oncology News, Insights, Stories by OncoDaily

Fadlo R. Khuri
Voices

Fadlo R. Khuri: Breast Cancer is Among the Most Preventable and Curable Diseases of Our Century

Napoli 3
New Paper Alert

NAPOLI 3 Subgroup Analysis: NALIRIFOX in Older Patients With Metastatic Pancreatic Cancer

OncoDaily Weekly
Not To Miss

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

The Drink in Your Glass Is a Group 1 Carcinogen. So Why Do We Toast With It?

10 Must-Read Posts in Immuno-Oncology This Week

Evis Sala: Italy's and Albania's Shared Commitment for the First Formal Cooperation Agreement

Bente Mikkelsen: Sri Lanka Joins the Global Platform for Access to Childhood Cancer Medicines

Flash Radiotherapy: The 0.1-Second Cancer Treatment That Could Revolutionize Oncology

Cancer Care Drives Radiopharmaceuticals Market Past $21B by 2033

Carlos Rodriguez-Galindo: This is More Than Research. This is Hope in Action

OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Nutrition - OncoDaily

Nutrition Across the Cancer Continuum: Prevention, Treatment, Recovery

How Financial Wellness Starts Before Your First Attending Job - Hem-Onc Fellows Network

Alex Hotca on SBRT for Hepatocellular Carcinoma at HCC Live 2026

Matt Spraker: How VMAT Improves Safety in Treating Abdominopelvic Soft-Tissue Sarcomas

Yüksel Ürün: Why Focal Therapy Matches Surgery in Radiorecurrent Prostate Cancer

Amol Akhade: ASCO GU 2026 Updates for a Global Oncology Community

Mali Barbi: Why pCR Isn’t the Finish Line in HER2-Positive Breast Cancer

FDA Approvals
FDA-Optune Pax

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

2nd Pediatric and Neonatal Palliative Care Symposium

Chance Association

25 Feb
Palliative Care

Restoring Trust in Science: Storytelling, AI, and Integrity in Scholarly Publishing

International Society for Medical Publication Professionals

26 Mar
Science

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop

British Society of Haematology

25 Feb
British Society of Haematology

Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment

Sharing Progress in Cancer Care

23 Apr
Breast Cancer Treatment

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

Immune-oncology
The Myth of Lifelong Immunotherapy

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

OncoDaily TV
Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

ASH Highlights 2026: Insights from Dr Heghine Khachatryan

International Childhood Cancer Day 2026: Powerful Voices, Lifesaving Hope

International Day of Women and Girls in Science 2026

15 Posts Not To Miss from AMSTRO 2026

Oncology This Week: OncoDaily Weekly Feb 2-8, 2026

Exciting News: OncoDaily's Managing Editor Dr Elen Baloyan Releases Her 1st Mini-EP

OncoGrants
2026 Cancer Center at Illinois Seed Grant Program

2026 Cancer Center at Illinois Seed Grant Program

2026 AIM-HI Women’s Venture Competition

2026 AIM-HI Women’s Venture Competition

SickKids Meagan Bebenek Neuro-Oncology Fellowship

SickKids Meagan Bebenek Neuro-Oncology Fellowship

2026 AIM-HI BRACE Award Venture Competition

2026 AIM-HI BRACE Award Venture Competition

Horizon Europe Mission Cancer: CANCER-01 Virtual Human Twin Models for Cancer Research

Horizon Europe Mission Cancer: CANCER-01 Virtual Human Twin Models for Cancer Research

CUASF Academic–Community Collaboration Award

CUASF Academic–Community Collaboration Award

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Rana McKay

Rana R. McKay

Oncologists Location San Diego, USA
Matti Aapro

Matti Aapro

Oncologists Location Genolier, Switzerland
Florian Scotté

Florian Scotté

Oncologists Location Paris, France
Melvin L.K. Chua

Melvin L.K. Chua

Oncologists Location Singapore, Singapore
Samvel Bardakhchyan

Samvel Bardakhchyan

Oncologists Location Yerevan, Armenia
Mohamed Emam Sobeih

Mohamed Emam Sobeih

Oncologists Location Giza, Egypt
Justin Nathaniel Baker

Justin Nathaniel Baker

Oncologists Location Stanford, USA
Khushali Jhaveri

Khushali Jhaveri

Oncologists Location Indianapolis, USA

Oncology Drugs
GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

Iza-Bren (EGFR×HER3 ADC): A Patient-Friendly Guide To A New Cancer Treatment

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
Napoli 3

NAPOLI 3 Subgroup Analysis: NALIRIFOX in Older Patients With Metastatic Pancreatic Cancer

KEYVIBE-010 Trial

KEYVIBE-010 Trial: Vibostolimab–Pembrolizumab vs Pembrolizumab in Adjuvant High-Risk Melanoma

SBRT

Biochemical Control and 2-Year Tolerability After SBRT for Localized Prostate Cancer

PATINA Trial: Palbociclib in Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

PATINA Trial: Palbociclib in Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

ARTS Trial

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC

CATNON Trial

CATNON Final Analysis: Defining the Role of Adjuvant Temozolomide in IDH-Mutant Grade 3 Astrocytoma

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts